These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 24047859

  • 1. The clinical significance of antimicrobial serologic responses within an Irish Crohn's disease population.
    O'Donnell S, O'Sullivan M, O'Morain CA, Ryan BM.
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1464-9. PubMed ID: 24047859
    [Abstract] [Full Text] [Related]

  • 2. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A, Zurakowski D, Young W, Leichtner A, Bousvaros A.
    Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
    [Abstract] [Full Text] [Related]

  • 3. Serological antibodies and surgery in a population-based inception cohort of Crohn's disease patients - the IBSEN study.
    Kristensen VA, Cvancarova M, Høivik ML, Moum B, Vatn MH.
    Scand J Gastroenterol; 2020 Apr; 55(4):436-441. PubMed ID: 32252542
    [Abstract] [Full Text] [Related]

  • 4. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.
    Gologan S, Iacob R, Preda C, Vadan R, Cotruta B, Catuneanu AM, Iacob S, Constantinescu I, Gheorghe L, Iobagiu S, Gheorghe C, Diculescu M.
    J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Analysis of serum antibodies in patients suspected of having inflammatory bowel disease.
    Jaskowski TD, Litwin CM, Hill HR.
    Clin Vaccine Immunol; 2006 Jun; 13(6):655-60. PubMed ID: 16760323
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease.
    Esters N, Vermeire S, Joossens S, Noman M, Louis E, Belaiche J, De Vos M, Van Gossum A, Pescatore P, Fiasse R, Pelckmans P, Reynaert H, Poulain D, Bossuyt X, Rutgeerts P, Belgian Group of Infliximab Expanded Access Program in Crohn's Disease.
    Am J Gastroenterol; 2002 Jun; 97(6):1458-62. PubMed ID: 12094865
    [Abstract] [Full Text] [Related]

  • 9. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype.
    Arnott ID, Landers CJ, Nimmo EJ, Drummond HE, Smith BK, Targan SR, Satsangi J.
    Am J Gastroenterol; 2004 Dec; 99(12):2376-84. PubMed ID: 15571586
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases.
    Saibeni S, Folli C, de Franchis R, Borsi G, Vecchi M.
    Dig Liver Dis; 2003 Dec; 35(12):862-8. PubMed ID: 14703881
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Gene polymorphisms and serological markers of patients with active Crohn's disease in a clinical trial of antisense to ICAM-1.
    Yacyshyn BR, Schievella A, Sewell KL, Tami JA.
    Clin Exp Immunol; 2005 Jul; 141(1):141-7. PubMed ID: 15958080
    [Abstract] [Full Text] [Related]

  • 13. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases.
    Bartůnková J, Kolárová I, Sedivá A, Hölzelová E.
    Clin Immunol; 2002 Feb; 102(2):162-8. PubMed ID: 11846458
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical utility of serological markers in inflammatory bowel disease.
    Mokrowiecka A, Daniel P, Słomka M, Majak P, Malecka-Panas E.
    Hepatogastroenterology; 2009 Feb; 56(89):162-6. PubMed ID: 19453050
    [Abstract] [Full Text] [Related]

  • 16. Serum antibodies and anthropometric data at diagnosis in pediatric Crohn's disease.
    Trauernicht AK, Steiner SJ.
    Dig Dis Sci; 2012 Apr; 57(4):1020-5. PubMed ID: 22075854
    [Abstract] [Full Text] [Related]

  • 17. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
    Papp M, Altorjay I, Dotan N, Palatka K, Foldi I, Tumpek J, Sipka S, Udvardy M, Dinya T, Lakatos L, Kovacs A, Molnar T, Tulassay Z, Miheller P, Norman GL, Szamosi T, Papp J, Hungarian IBD Study Group, Lakatos PL.
    Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic role and clinical association of ASCA and ANCA in Brazilian patients with inflammatory bowel disease.
    Nisihara RM, de Carvalho WB, Utiyama SR, Amarante H, Baptista ML.
    Dig Dis Sci; 2010 Aug; 55(8):2309-15. PubMed ID: 19826949
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antibodies to Escherichia coli outer membrane porin C in the absence of anti-Saccharomyces cerevisiae antibodies and anti-neutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis.
    Davis MK, Andres JM, Jolley CD, Novak DA, Haafiz AB, González-Peralta RP.
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):409-13. PubMed ID: 18030205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.